ralimetinib (Compound)

Synonyms:Ralimetinib, 862505-00-8, LY-2228820, LY-2228820 free base, Ralimetinib ( LY2228820), 862505-00-8 (free base), 73I34XW4HD, LSN2322600 FREE BASE, LSN-2322600 FREE BASE, 3H-Imidazo(4,5-b)pyridin-2-amine, 5-(2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-, 3H-Imidazo[4,5-b]pyridin-2-amine,5-[2-(1,1-dimethylethyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl]-3-(2,2-dimethylpropyl)-, 5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine, 5-(2-(tert-butyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine, Ralimetinib [USAN:INN], LY2228820 free base, UNII-73I34XW4HD, 5-(2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL)-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO(4,5-B)PYRIDIN-2-YLAMINE, 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1H-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3H-imidazo[4,5-b]pyridin-2-ylamine, Ralimetinib [INN], Ralimetinib (USAN/INN), RALIMETINIB [USAN], RALIMETINIB [WHO-DD], 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-Imidazo[4,5-b]pyridin-2-amine, GTPL7959, SCHEMBL3989306, CHEMBL2364626, SCHEMBL13826263, DTXSID00235456, BCPP000180, HMS3674E21, BCP02033, HY-13241A, NSC766820, NSC785335, AKOS027282678, BCP9000871, DB11787, NSC-766820, NSC-785335, SB16635, NCGC00346537-01, NCGC00346537-03, NCGC00346537-05, DB-076584, CS-0008496, FT-0727743, LY22288220, D10658, E98891, Q27088512, 5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine, 5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine, 5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine, 5-[2-tert-butyl-5-(4-fluorophenyl)-3H-imidazol-4-yl]-3-(2,2-dimethylpropyl)imidazo[5,4-b]pyridin-2-amine

Pubchem:PUBCHEM:11539025

Id:d34ae289-d6b2-50f3-ab4d-3f22e7a02a19

Description:nan